Anaphylaxis, An Issue of Immunology and Allergy Clinics of North America
- 1 Edición, Volumen 46-2 - 6 de abril de 2026
- Última edición
- Editor: Marcus S. Shaker
- Idioma: Inglés
In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updat… Leer más
Descripción
Descripción
In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updates on anaphylaxis epidemiology, guidelines, and diagnostics, as well as mast cell activation syndrome, mastocytosis, novel therapies, and more.
Puntos claves
Puntos claves
- Contains 15 relevant, practice-oriented topics including venom anaphylaxis; anaphylaxis guidelines; equity and anaphylaxis; future anaphylaxis therapies; novel epinephrine delivery devices; preventing food anaphylaxis; and more
- Provides in-depth clinical reviews on anaphylaxis, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
De interès para
De interès para
Allergists
Índice
Índice
Anaphylaxis Epidemiology and Risk Factors
Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses
Community Anaphylaxis
Equity and Anaphylaxis
Anaphylaxis Guidelines
Preventing Food Anaphylaxis
Drug Anaphylaxis
Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis
Iodinated Contrast Media and Anaphylaxis
Venom Anaphylaxis
Novel Epinephrine Delivery Devices
Emerging Therapies for Anaphylaxis
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis
Mast Cell Activation Syndrome and Mimickers
Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses
Community Anaphylaxis
Equity and Anaphylaxis
Anaphylaxis Guidelines
Preventing Food Anaphylaxis
Drug Anaphylaxis
Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis
Iodinated Contrast Media and Anaphylaxis
Venom Anaphylaxis
Novel Epinephrine Delivery Devices
Emerging Therapies for Anaphylaxis
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis
Mast Cell Activation Syndrome and Mimickers
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 46-2
- Publicado: 10 de abril de 2026
- Idioma: Inglés
Sobre el editor
Sobre el editor
MS
Marcus S. Shaker
Afiliaciones y experiencia
Professor of Pediatrics and Medicine, Department of Allergy and Clinical Immunology Dartmouth Hitchcock Medical Center, Department of Pediatric Allergy, Dartmouth Health Children's, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA